157 related articles for article (PubMed ID: 8208120)
21. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies.
Lebdusková P; Hermann P; Helm L; Tóth E; Kotek J; Binnemans K; Rudovský J; Lukes I; Merbach AE
Dalton Trans; 2007 Jan; (4):493-501. PubMed ID: 17213936
[TBL] [Abstract][Full Text] [Related]
22. Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents.
Chan KW; Barra S; Botta M; Wong WT
J Inorg Biochem; 2004 May; 98(5):677-82. PubMed ID: 15134912
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
Laurent S; Elst LV; Muller RN
Contrast Media Mol Imaging; 2006; 1(3):128-37. PubMed ID: 17193689
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical characterization of the dimeric lanthanide complexes [en{Ln(DO3A)(H2O)}2] and [pi{Ln(DTTA)(H2O)}2]2-: a variable-temperature 17O NMR study.
Lee TM; Cheng TH; Ou MH; Chang CA; Liu GC; Wang YM
Magn Reson Chem; 2004 Mar; 42(3):329-36. PubMed ID: 14971018
[TBL] [Abstract][Full Text] [Related]
25. Towards an Improved Design of MRI Contrast Agents: Synthesis and Relaxometric Characterisation of Gd-HPDO3A Analogues.
Tear LR; Carrera C; Gianolio E; Aime S
Chemistry; 2020 May; 26(27):6056-6063. PubMed ID: 32133687
[TBL] [Abstract][Full Text] [Related]
26. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation.
Idée JM; Berthommier C; Goulas V; Corot C; Santus R; Hermine C; Schaefer M; Bonnemain B
Biometals; 1998 Apr; 11(2):113-23. PubMed ID: 9542065
[TBL] [Abstract][Full Text] [Related]
27. NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.
Morel S; Terreno E; Ugazio E; Aime S; Gasco MR
Eur J Pharm Biopharm; 1998 Mar; 45(2):157-63. PubMed ID: 9704912
[TBL] [Abstract][Full Text] [Related]
28. Relaxivity of Gd-Based MRI Contrast Agents in Crosslinked Hyaluronic Acid as a Model for Tissues.
Fragai M; Ravera E; Tedoldi F; Luchinat C; Parigi G
Chemphyschem; 2019 Sep; 20(17):2204-2209. PubMed ID: 31298452
[TBL] [Abstract][Full Text] [Related]
29. Preparation, physico-chemical characterization, and relaxometry studies of various gadolinium(III)-DTPA-bis(amide) derivatives as potential magnetic resonance contrast agents.
Geraldes CF; Urbano AM; Alpoim MC; Sherry AD; Kuan KT; Rajagopalan R; Maton F; Muller RN
Magn Reson Imaging; 1995; 13(3):401-20. PubMed ID: 7791550
[TBL] [Abstract][Full Text] [Related]
30. Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).
Brugières P; Gaston A; Degryse HR; Parizel PM; de Schepper AM; Berry I; Manelfe C; Le Bras F; Marsault C; Wichmann W
Neuroradiology; 1994; 36(1):27-30. PubMed ID: 8107991
[TBL] [Abstract][Full Text] [Related]
31. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
Burai L; Tóth E; Sour A; Merbach AE
Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
[TBL] [Abstract][Full Text] [Related]
32. From the relaxivity of Gd(DTPA)2- to everything else.
Koenig SH
Magn Reson Med; 1991 Dec; 22(2):183-90. PubMed ID: 1812344
[TBL] [Abstract][Full Text] [Related]
33. Multinuclear MR characterization of a new hepatobiliary contrast agent. Preliminary results.
Vander Elst L; Maton F; Laurent S; Seghi F; Muller RN
Acta Radiol Suppl; 1997; 412():135-8. PubMed ID: 9240092
[TBL] [Abstract][Full Text] [Related]
34. Unexpected aggregation of neutral, xylene-cored dinuclear GdIII chelates in aqueous solution.
Costa J; Balogh E; Turcry V; Tripier R; Le Baccon M; Chuburu F; Handel H; Helm L; Tóth E; Merbach AE
Chemistry; 2006 Sep; 12(26):6841-51. PubMed ID: 16770815
[TBL] [Abstract][Full Text] [Related]
35. Effects of radiation on the NMR relaxation effects of aqueous solutions of gadolinium contrast agents.
Gultekin DH; Raidy TE; Gore JC
Contrast Media Mol Imaging; 2009; 4(1):33-6. PubMed ID: 19061179
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme.
Corot C; Idee JM; Hentsch AM; Santus R; Mallet C; Goulas V; Bonnemain B; Meyer D
J Magn Reson Imaging; 1998; 8(3):695-702. PubMed ID: 9626889
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical properties of the high-field MRI-relevant [Gd(DTTA-Me)(H2O)2]- complex.
Moriggi L; Cannizzo C; Prestinari C; Berrière F; Helm L
Inorg Chem; 2008 Sep; 47(18):8357-66. PubMed ID: 18714983
[TBL] [Abstract][Full Text] [Related]
38. The synthesis and evaluation of macrocyclic gadolinium-DTPA-bis(amide) complexes as magnetic resonance imaging contrast agents.
Varadarajan JA; Crofts SP; Carvalho JF; Fellmann JD; Kim SH; Chang CA; Watson AD
Invest Radiol; 1994 Jun; 29 Suppl 2():S18-20. PubMed ID: 7928223
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of paramagnetic polychelates and their protein conjugates.
Sieving PF; Watson AD; Rocklage SM
Bioconjug Chem; 1990; 1(1):65-71. PubMed ID: 2095206
[TBL] [Abstract][Full Text] [Related]
40. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
